NOV 19, 2015 9:20 AM PST

Finally Catching Small Cell Lung Cancer Before Metastasis

WRITTEN BY: Kara Marker
Small cell lung cancer (SCLC) has a long history of evading both the immune system and scientists trying to study how it does so, and patients with SCLC rarely get diagnosed before the cancer has metastasized. Scientists from the Medical University of Vienna in Austria, where increasing amounts of people are dying from lung cancer, were finally able to obtain enough cancer cell material to determine how these tumors remain so pervasive. Dr. Gerhard Hamilton, leader of the study, and his team published their findings this week in OncoImmunology.

Difficulty in SCLC detection most often leads to poor prognoses and harsh treatments. Irradiation and cytotoxic chemotherapy are the only options, since surgery is ineffective. Cytotoxic chemotherapy drugs are injected into the bloodstream with the goal of impeding cancer cell ability to divide and grow, leading to their destruction (Northern Health and Social Care Trust). Normal human cells also need to divide and grow to survive though, so this therapy often has unfortunate side effects for cancer patients. In both Austria and America where lung cancer kills thousands of people every year, about 15% of lung cancers are diagnosed as SCLC, most often in people who have a history of smoking (Cancer.org). 

Scientists studying SCLC constantly had trouble obtaining "enough cell material available for biomolecular analysis," a major roadblock in figuring out how tumors would shrink initially after chemotherapy and then return resistant to the harshest treatments. In developing a new method for obtaining and cultivating samples for study, Hamilton and his team have made major advances in the battle against SCLC.

Their established method for "cultivating the circulating tumor cells (CTCs)" made it possible for the team to determine the mechanisms behind the cancer cells' immune system evasion.

First, CTCs manipulate the local microenvironment to stimulate monocyte differentiation into macrophages. At first this seems counterintuitive since macrophages function to phagocytose abnormal cells like tumor cells. However, CTCs also alter macrophage cytokine expression to the point where the lymphocytes not only fail to attack and kill the cancerous cells, but also change the local conditions themselves to enhance CTCs' ability to spread.

In the words of the scientific team, "CTCs are competent to specifically manipulate tumor-associated macrophages to increase invasiveness, angiogenesis, immunosuppression, and possibly lipid catabolism."

Now that the team from Vienna understands monumentally more about SCLC evasion of the immune system, the next step is to determine how cancer recurrence is accompanied by resistance to treatment. 

Watch the following video to learn more about how SCLC is diagnosed and how doctors create treatment plans.

Source: University Department of Surgery at the Medical University of Vienna



 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 25, 2019
Drug Discovery & Development
OCT 25, 2019
Novel Therapeutic For Eradicating The Flu Virus
Public Health officials have long warned about pandemic pathogens flying fast around the world. One virus already spreads across the globe annually leading
DEC 20, 2019
Neuroscience
DEC 20, 2019
Does Having Herpes Increase Your Risk for Alzheimer's?
Around 44 million people around the world have Alzheimer’s disease, a progressive form of dementia that leads to memory loss and a decline in cogniti
JAN 14, 2020
Clinical & Molecular DX
JAN 14, 2020
Can I eat this donut? A quick test for celiac disease.
Genetic testing revealed that our ancestors have been eating wheat, rye, spelt and barley for over 8,000 years. Today, gluten, a protein found within these
FEB 07, 2020
Neuroscience
FEB 07, 2020
Eating Fruits and Vegetables May Lower Alzheimer's Risk
New research has found that flavonols, a large class of compounds present in many fruits and vegetables, may be linked to a lower risk of developing Alzhei
MAR 19, 2020
Drug Discovery & Development
MAR 19, 2020
Does Sucking Zinc Lozenges Help Fight off Coronavirus?
As panic is spreading over the novel coronavirus, the time is ripe for both misinformation and disinformation to thrive. In particular, sucking zinc lozeng
MAR 23, 2020
Drug Discovery & Development
MAR 23, 2020
Top 5 Candidates for Coronavirus Vaccine Around the World
It’s easy to complain about the role of big pharma in medicine-making and the hassle of dealing with protective patents when combating various diseas
Loading Comments...